Feng et al. developed a CNP-cardiolipin nanosystem that modulates the TLR4/NF-κB pathway to induce microglial polarization toward the M2 phenotype, thereby effectively improving AD pathology [13]. The gene discussed is TLR4; the disease is Alzheimer disease.